Cargando…

Availability of screening and treatment for common mental disorders in HIV clinic settings: data from the global International epidemiology Databases to Evaluate AIDS (IeDEA) Consortium, 2016–2017 and 2020

INTRODUCTION: Common mental disorders (CMDs) are highly prevalent among people with HIV. Integrating mental healthcare into HIV care may improve mental health and HIV treatment outcomes. We describe the reported availability of screening and treatment for depression, anxiety and post‐traumatic stres...

Descripción completa

Detalles Bibliográficos
Autores principales: Parcesepe, Angela M., Stockton, Melissa, Remch, Molly, Wester, C. William, Bernard, Charlotte, Ross, Jeremy, Haas, Andreas D., Ajeh, Rogers, Althoff, Keri N., Enane, Leslie, Pape, William, Minga, Albert, Kwobah, Edith, Tlali, Mpho, Tanuma, Junko, Nsonde, Dominique, Freeman, Aimee, Duda, Stephany N., Nash, Denis, Lancaster, Kathryn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399924/
https://www.ncbi.nlm.nih.gov/pubmed/37535703
http://dx.doi.org/10.1002/jia2.26147
_version_ 1785084354673770496
author Parcesepe, Angela M.
Stockton, Melissa
Remch, Molly
Wester, C. William
Bernard, Charlotte
Ross, Jeremy
Haas, Andreas D.
Ajeh, Rogers
Althoff, Keri N.
Enane, Leslie
Pape, William
Minga, Albert
Kwobah, Edith
Tlali, Mpho
Tanuma, Junko
Nsonde, Dominique
Freeman, Aimee
Duda, Stephany N.
Nash, Denis
Lancaster, Kathryn
author_facet Parcesepe, Angela M.
Stockton, Melissa
Remch, Molly
Wester, C. William
Bernard, Charlotte
Ross, Jeremy
Haas, Andreas D.
Ajeh, Rogers
Althoff, Keri N.
Enane, Leslie
Pape, William
Minga, Albert
Kwobah, Edith
Tlali, Mpho
Tanuma, Junko
Nsonde, Dominique
Freeman, Aimee
Duda, Stephany N.
Nash, Denis
Lancaster, Kathryn
author_sort Parcesepe, Angela M.
collection PubMed
description INTRODUCTION: Common mental disorders (CMDs) are highly prevalent among people with HIV. Integrating mental healthcare into HIV care may improve mental health and HIV treatment outcomes. We describe the reported availability of screening and treatment for depression, anxiety and post‐traumatic stress disorder (PTSD) at global HIV treatment centres participating in the International epidemiology Databases to Evaluate AIDS (IeDEA) Consortium in 2020 and changes in availability at sites in low‐ or middle‐income countries (LMICs) between 2016/2017 and 2020. METHODS: In 2020, 238 sites contributing individual‐level data to the IeDEA Consortium and in 2016/2017 a stratified random sample of IeDEA sites in LMICs were eligible to participate in site surveys on the availability of screening and treatment for CMDs. We assessed trends over time for 68 sites across 27 LMICs that participated in both surveys. RESULTS: Among the 238 sites eligible to participate in the 2020 site survey, 227 (95%) participated, and mental health screening and treatment data were available for 223 (98%) sites across 41 countries. A total of 95 sites across 29 LMICs completed the 2016/2017 survey. In 2020, 68% of sites were in urban settings, and 77% were in LMICs. Overall, 50%, 14% and 12% of sites reported screening with a validated instrument for depression, anxiety and PTSD, respectively. Screening plus treatment in the form of counselling was available for depression, anxiety and PTSD at 46%, 13% and 11% of sites, respectively. Screening plus treatment in the form of medication was available for depression, anxiety and PTSD at 36%, 11% and 8% of sites, respectively. Among sites that participated in both surveys, screening for depression was more commonly available in 2020 than 2016/2017 (75% vs. 59%, respectively, p = 0.048). CONCLUSIONS: Reported availability of screening for depression increased among this group of IeDEA sites in LMICs between 2016/2017 and 2020. However, substantial gaps persist in the availability of mental healthcare at HIV treatment sites across global settings, particularly in resource‐constrained settings. Implementation of sustainable strategies to integrate mental health services into HIV care is needed.
format Online
Article
Text
id pubmed-10399924
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-103999242023-08-04 Availability of screening and treatment for common mental disorders in HIV clinic settings: data from the global International epidemiology Databases to Evaluate AIDS (IeDEA) Consortium, 2016–2017 and 2020 Parcesepe, Angela M. Stockton, Melissa Remch, Molly Wester, C. William Bernard, Charlotte Ross, Jeremy Haas, Andreas D. Ajeh, Rogers Althoff, Keri N. Enane, Leslie Pape, William Minga, Albert Kwobah, Edith Tlali, Mpho Tanuma, Junko Nsonde, Dominique Freeman, Aimee Duda, Stephany N. Nash, Denis Lancaster, Kathryn J Int AIDS Soc Research Articles INTRODUCTION: Common mental disorders (CMDs) are highly prevalent among people with HIV. Integrating mental healthcare into HIV care may improve mental health and HIV treatment outcomes. We describe the reported availability of screening and treatment for depression, anxiety and post‐traumatic stress disorder (PTSD) at global HIV treatment centres participating in the International epidemiology Databases to Evaluate AIDS (IeDEA) Consortium in 2020 and changes in availability at sites in low‐ or middle‐income countries (LMICs) between 2016/2017 and 2020. METHODS: In 2020, 238 sites contributing individual‐level data to the IeDEA Consortium and in 2016/2017 a stratified random sample of IeDEA sites in LMICs were eligible to participate in site surveys on the availability of screening and treatment for CMDs. We assessed trends over time for 68 sites across 27 LMICs that participated in both surveys. RESULTS: Among the 238 sites eligible to participate in the 2020 site survey, 227 (95%) participated, and mental health screening and treatment data were available for 223 (98%) sites across 41 countries. A total of 95 sites across 29 LMICs completed the 2016/2017 survey. In 2020, 68% of sites were in urban settings, and 77% were in LMICs. Overall, 50%, 14% and 12% of sites reported screening with a validated instrument for depression, anxiety and PTSD, respectively. Screening plus treatment in the form of counselling was available for depression, anxiety and PTSD at 46%, 13% and 11% of sites, respectively. Screening plus treatment in the form of medication was available for depression, anxiety and PTSD at 36%, 11% and 8% of sites, respectively. Among sites that participated in both surveys, screening for depression was more commonly available in 2020 than 2016/2017 (75% vs. 59%, respectively, p = 0.048). CONCLUSIONS: Reported availability of screening for depression increased among this group of IeDEA sites in LMICs between 2016/2017 and 2020. However, substantial gaps persist in the availability of mental healthcare at HIV treatment sites across global settings, particularly in resource‐constrained settings. Implementation of sustainable strategies to integrate mental health services into HIV care is needed. John Wiley and Sons Inc. 2023-08-03 /pmc/articles/PMC10399924/ /pubmed/37535703 http://dx.doi.org/10.1002/jia2.26147 Text en © 2023 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Parcesepe, Angela M.
Stockton, Melissa
Remch, Molly
Wester, C. William
Bernard, Charlotte
Ross, Jeremy
Haas, Andreas D.
Ajeh, Rogers
Althoff, Keri N.
Enane, Leslie
Pape, William
Minga, Albert
Kwobah, Edith
Tlali, Mpho
Tanuma, Junko
Nsonde, Dominique
Freeman, Aimee
Duda, Stephany N.
Nash, Denis
Lancaster, Kathryn
Availability of screening and treatment for common mental disorders in HIV clinic settings: data from the global International epidemiology Databases to Evaluate AIDS (IeDEA) Consortium, 2016–2017 and 2020
title Availability of screening and treatment for common mental disorders in HIV clinic settings: data from the global International epidemiology Databases to Evaluate AIDS (IeDEA) Consortium, 2016–2017 and 2020
title_full Availability of screening and treatment for common mental disorders in HIV clinic settings: data from the global International epidemiology Databases to Evaluate AIDS (IeDEA) Consortium, 2016–2017 and 2020
title_fullStr Availability of screening and treatment for common mental disorders in HIV clinic settings: data from the global International epidemiology Databases to Evaluate AIDS (IeDEA) Consortium, 2016–2017 and 2020
title_full_unstemmed Availability of screening and treatment for common mental disorders in HIV clinic settings: data from the global International epidemiology Databases to Evaluate AIDS (IeDEA) Consortium, 2016–2017 and 2020
title_short Availability of screening and treatment for common mental disorders in HIV clinic settings: data from the global International epidemiology Databases to Evaluate AIDS (IeDEA) Consortium, 2016–2017 and 2020
title_sort availability of screening and treatment for common mental disorders in hiv clinic settings: data from the global international epidemiology databases to evaluate aids (iedea) consortium, 2016–2017 and 2020
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399924/
https://www.ncbi.nlm.nih.gov/pubmed/37535703
http://dx.doi.org/10.1002/jia2.26147
work_keys_str_mv AT parcesepeangelam availabilityofscreeningandtreatmentforcommonmentaldisordersinhivclinicsettingsdatafromtheglobalinternationalepidemiologydatabasestoevaluateaidsiedeaconsortium20162017and2020
AT stocktonmelissa availabilityofscreeningandtreatmentforcommonmentaldisordersinhivclinicsettingsdatafromtheglobalinternationalepidemiologydatabasestoevaluateaidsiedeaconsortium20162017and2020
AT remchmolly availabilityofscreeningandtreatmentforcommonmentaldisordersinhivclinicsettingsdatafromtheglobalinternationalepidemiologydatabasestoevaluateaidsiedeaconsortium20162017and2020
AT westercwilliam availabilityofscreeningandtreatmentforcommonmentaldisordersinhivclinicsettingsdatafromtheglobalinternationalepidemiologydatabasestoevaluateaidsiedeaconsortium20162017and2020
AT bernardcharlotte availabilityofscreeningandtreatmentforcommonmentaldisordersinhivclinicsettingsdatafromtheglobalinternationalepidemiologydatabasestoevaluateaidsiedeaconsortium20162017and2020
AT rossjeremy availabilityofscreeningandtreatmentforcommonmentaldisordersinhivclinicsettingsdatafromtheglobalinternationalepidemiologydatabasestoevaluateaidsiedeaconsortium20162017and2020
AT haasandreasd availabilityofscreeningandtreatmentforcommonmentaldisordersinhivclinicsettingsdatafromtheglobalinternationalepidemiologydatabasestoevaluateaidsiedeaconsortium20162017and2020
AT ajehrogers availabilityofscreeningandtreatmentforcommonmentaldisordersinhivclinicsettingsdatafromtheglobalinternationalepidemiologydatabasestoevaluateaidsiedeaconsortium20162017and2020
AT althoffkerin availabilityofscreeningandtreatmentforcommonmentaldisordersinhivclinicsettingsdatafromtheglobalinternationalepidemiologydatabasestoevaluateaidsiedeaconsortium20162017and2020
AT enaneleslie availabilityofscreeningandtreatmentforcommonmentaldisordersinhivclinicsettingsdatafromtheglobalinternationalepidemiologydatabasestoevaluateaidsiedeaconsortium20162017and2020
AT papewilliam availabilityofscreeningandtreatmentforcommonmentaldisordersinhivclinicsettingsdatafromtheglobalinternationalepidemiologydatabasestoevaluateaidsiedeaconsortium20162017and2020
AT mingaalbert availabilityofscreeningandtreatmentforcommonmentaldisordersinhivclinicsettingsdatafromtheglobalinternationalepidemiologydatabasestoevaluateaidsiedeaconsortium20162017and2020
AT kwobahedith availabilityofscreeningandtreatmentforcommonmentaldisordersinhivclinicsettingsdatafromtheglobalinternationalepidemiologydatabasestoevaluateaidsiedeaconsortium20162017and2020
AT tlalimpho availabilityofscreeningandtreatmentforcommonmentaldisordersinhivclinicsettingsdatafromtheglobalinternationalepidemiologydatabasestoevaluateaidsiedeaconsortium20162017and2020
AT tanumajunko availabilityofscreeningandtreatmentforcommonmentaldisordersinhivclinicsettingsdatafromtheglobalinternationalepidemiologydatabasestoevaluateaidsiedeaconsortium20162017and2020
AT nsondedominique availabilityofscreeningandtreatmentforcommonmentaldisordersinhivclinicsettingsdatafromtheglobalinternationalepidemiologydatabasestoevaluateaidsiedeaconsortium20162017and2020
AT freemanaimee availabilityofscreeningandtreatmentforcommonmentaldisordersinhivclinicsettingsdatafromtheglobalinternationalepidemiologydatabasestoevaluateaidsiedeaconsortium20162017and2020
AT dudastephanyn availabilityofscreeningandtreatmentforcommonmentaldisordersinhivclinicsettingsdatafromtheglobalinternationalepidemiologydatabasestoevaluateaidsiedeaconsortium20162017and2020
AT nashdenis availabilityofscreeningandtreatmentforcommonmentaldisordersinhivclinicsettingsdatafromtheglobalinternationalepidemiologydatabasestoevaluateaidsiedeaconsortium20162017and2020
AT lancasterkathryn availabilityofscreeningandtreatmentforcommonmentaldisordersinhivclinicsettingsdatafromtheglobalinternationalepidemiologydatabasestoevaluateaidsiedeaconsortium20162017and2020
AT availabilityofscreeningandtreatmentforcommonmentaldisordersinhivclinicsettingsdatafromtheglobalinternationalepidemiologydatabasestoevaluateaidsiedeaconsortium20162017and2020